Data / Form D filings / EVESTRA INC
EVESTRA INC: Form D filings
EVESTRA INC, a pharmaceuticals company in San Antonio, TX, filed 3 Form D notices with the SEC in 2009. The latest, on December 15, 2009, reports $1.8 million sold of a $4 million offering to 14 investors.
Find out what EVESTRA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7620 NW LOOP 410, San Antonio, TX, 78227
- Phone
- (210) 673-3300
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1440876
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 15, 2009 | Amendment | $4,000,000 | $1,800,000 | $2,200,000 | 14 | Oct 19, 2009 | sec.gov |
| Dec 15, 2009 | Amendment | $4,000,000 | $1,800,000 | $2,200,000 | 14 | Yet to occur | sec.gov |
| Dec 14, 2009 | New notice | $4,000,000 | $1,800,000 | $2,200,000 | 14 | Oct 19, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Hurd R. John | Director | |
| Klaus Nickisch | Executive Officer, Director | |
| John C. Kerr | Director | |
| Ze'ev Shaked | Executive Officer, Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Dec 14, 2009 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what EVESTRA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.